Measuring medicine prices in Peru

Validation of key aspects of WHO/HAI survey methodology

Datos Bibliográficos

ID14966111
AutoresJ M Madden (0000-0001-6075-7898, Harvard Pilgrim Health Care, autor de correspondencia), Edson Meza (International Potato Center), Margaret Ewen (0000-0003-1177-4717, Health Action International), Richard Laing (0000-0002-3825-217X, Center For Policy Research), RICHARD O LAING, Peter Stephens (IQVIA (United States)), Dennis Ross-Degnan (0000-0002-0066-1242, Harvard University)
Año2010
Volumen27
Número4
Páginas291-299
Fecha de publicación2010-04-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaRevista Panamericana de Salud Pública (JOURNAL)
Identificadores de la revistaISSN: 1020-4989 • E-ISSN: 1680-5348
EditorialFapUNIFESP (SciELO) (PUBLISHER)
DOI10.1590/s1020-49892010000400008
PMID20512232
OpenAlexW1963611132
SCIELO_PIDS1020-49892010000400008
IdiomaEN
Citas recibidas6
Referencias citadas3

The WHO/HAI survey approach strikes an appropriate balance between modest research costs and optimal information for policy. Focusing on commonly used medicines yields sufficient and valid results. Surveyors elsewhere should consider the limits of the survey data as well as any local circumstances, such as scarcity, that may call for extra field efforts

Business · Economics · Product (mathematics · Sample (material · Scarcity · Statistics · Survey data collection · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Pharmaceutical Economics and Policy · Marketing